A Study to Assess the Safety, Tolerability and Efficacy of ION775
Start Date
5/12/2026
Completion Date
3/1/2028
Summary
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Detailed Description
This is an open-label, parallel-dose study consisting of a 4-6 week screening period, a 6-month treatment period and a 6-month post-treatment follow-up period.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
ION775
Conditions
Locations
Ionis Investigative Site
Lincoln, California 95648
United States
Ionis Investigative Site
Aurora, Colorado 80045
United States
Ionis Investigative Site
Boca Raton, Florida 33434
United States
Ionis Investigative Site
Miami, Florida 33184
United States
Ionis Investigative Site
Miramar, Florida 33027
United States
Ionis Investigative Site
Columbus, Georgia 31904
United States
Ionis Investigative Site
Louisville, Kentucky 40213
United States
Ionis Investigative Site
Flint, Michigan 48504
United States
Ionis Investigative Site
Munroe Falls, Ohio 44262
United States
Ionis Investigative Site
Little River, South Carolina 29566
United States
Ionis Investigative Site
Houston, Texas 77040
United States
Ionis Investigative Site
Lampasas, Texas 76550
United States
Ionis Investigative Site
McKinney, Texas 75071
United States
Ionis Investigative Site
Mesquite, Texas 75071
United States
Ionis Investigative Site
San Antonio, Texas 78209
United States
Ionis Investigative Site
Québec, G1V 4W2
Canada